Back to Search
Start Over
Romidepsin is an effective and well-tolerated therapy in CD3 - CD4 + lymphocyte-variant hypereosinophilic syndrome: A case report.
- Source :
-
The journal of allergy and clinical immunology. In practice [J Allergy Clin Immunol Pract] 2019 Nov - Dec; Vol. 7 (8), pp. 2885-2887.e1. Date of Electronic Publication: 2019 May 10. - Publication Year :
- 2019
- Subjects :
- Adult
CD3 Complex
CD4-Positive T-Lymphocytes
Depsipeptides administration & dosage
Depsipeptides adverse effects
Humans
Hypereosinophilic Syndrome immunology
Lymphoma, T-Cell drug therapy
Lymphoma, T-Cell immunology
Male
Phenotype
Depsipeptides therapeutic use
Hypereosinophilic Syndrome drug therapy
Subjects
Details
- Language :
- English
- ISSN :
- 2213-2201
- Volume :
- 7
- Issue :
- 8
- Database :
- MEDLINE
- Journal :
- The journal of allergy and clinical immunology. In practice
- Publication Type :
- Report
- Accession number :
- 31078759
- Full Text :
- https://doi.org/10.1016/j.jaip.2019.04.039